×
About 1,383 results

ALLMedicine™ Insulin Pumps Center

Research & Reviews  335 results

Advances in Diabetes and Cardiovascular Care
https://www.mdedge.com/fedprac/article/251040/diabetes/advances-diabetes-and-cardiovascular-care

Jan 20th, 2022 - Real-World Experience With Automated Insulin Pumps Continuous Blood Glucose Monitoring for T2DM Statin-Induced Adverse Effects Long QT and Cardiac Arrest After Pulmonary Edema And more online • Clinical Impact of U-500 Insulin Initiation • Diabete.

Beliefs Around Hypoglycemia and Their Impacts on Hypoglycemia Outcomes in Individuals w...
https://doi.org/10.2337/dc21-1285
Diabetes Care; Lin YK, Richardson CR et. al.

Jan 12th, 2022 - This study aimed to 1) identify the frequency of severe and level 2 hypoglycemia presenting in individuals with type 1 diabetes using continuous glucose monitoring systems (CGMs), including those with concomitant closed-loop insulin pumps, in a cl...

Psychometric properties of Turkish version of insulin delivery device satisfaction (IDS...
https://doi.org/10.1016/j.pcd.2022.01.001
Primary Care Diabetes; Bulantekin Düzalan Ö, İnkaya B

Jan 10th, 2022 - Various new insulin delivery devices (e.g., insulin pumps, digital insulin pens, continuous subcutaneous insulin infusion) and features have been introduced over the last decade, and even more are in development. Despite their benefits, however, u...

Benefits and risks of apps for patients.
https://doi.org/10.1097/MED.0000000000000701
Current Opinion in Endocrinology, Diabetes, and Obesity; Ahn DT

Dec 9th, 2021 - As smartphones have become deeply integrated into our daily lives, diabetes apps have emerged as valuable tools for people living with diabetes (PWD's). Whether as standalone apps or companion apps to diabetes devices such as glucose meters or ins...

Comparison of intrapartum glycemic management strategies in pregnant women with type 1 ...
https://doi.org/10.1080/14767058.2021.2004114
The Journal of Maternal-fetal & Neonatal Medicine : the O... Wilkie G, Orr L et. al.

Dec 7th, 2021 - Achieving intrapartum maternal euglycemia in women with type 1 diabetes mellitus (T1DM) is critical to reducing the risk of neonatal hypoglycemia. This study sought to compare the maternal and neonatal outcomes among women with T1DM by different i...

see more →

Guidelines  2 results

A Type 1 diabetes technology pathway: consensus statement for the use of technology in ...
https://doi.org/10.1111/dme.13933
Diabetic Medicine : a Journal of the British Diabetic Ass... Choudhary P, Campbell F et. al.

Feb 19th, 2019 - In both adults and children with diabetes, technologies such as continuous subcutaneous insulin infusion using insulin pumps and continuous glucose monitoring can help improve diabetes control, reduce hypoglycaemia and improve quality of life. Acc...

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY...
https://doi.org/10.4158/PS-2017-0155
Endocrine Practice : Official Journal of the American Col... Grunberger G, Handelsman Y et. al.

Mar 17th, 2018 - This document represents the official position of the American Association of Clinical Endocrinologists and American College of Endocrinology. Where there are no randomized controlled trials or specific U.S. FDA labeling for issues in clinical pra...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  20 results

Artificial Pancreas - Adolescent Physiology & Psychology Longitudinal Evaluation
https://clinicaltrials.gov/ct2/show/NCT04510506

Dec 6th, 2021 - The investigators will recruit adolescents with type 1 diabetes age 11-<13 years and one parent to participate in this 24-month study. While this is admittedly a long enrollment time, study commitments following enrollment will be limited to three...

The Impact of a Predictive Hypoglycaemia Alert Function in Physical Activity for People With T1DM
https://clinicaltrials.gov/ct2/show/NCT04142944

Nov 12th, 2021 - CLINIC VISIT 1: Screening Following informed consent study participants will give a full medical and medication history. Venous blood tests will be taken to assess HbA1c and renal function. C-peptide will be measured in participants who have not h...

A Study of LY900014 Versus Insulin Lispro (Humalog) on High Blood Sugar in Participants With Type 1 Diabetes Who Use Insulin Pumps
https://clinicaltrials.gov/ct2/show/NCT04276207

Aug 25th, 2021 - The main purpose of this study is to compare LY900014 to insulin lispro (Humalog) in participants with type 1 diabetes who are using an insulin pump and have high blood sugar after eating. For each participant, the study will last about two to nin...

Closed-loop Insulin Delivery In Type 1 Diabetes Pregnancies (CIRCUIT) - Internal Pilot
https://clinicaltrials.gov/ct2/show/NCT04902378

Jul 23rd, 2021 - Pregnant women with type 1 diabetes (T1D) require normal or near normal glucose in order to reduce the risks of birth defects, stillbirth, increased birthweight, neonatal hypoglycemia, neonatal death, preterm delivery and preeclampsia. Reducing ma...

Effectiveness of Video Consultations in Type 1 Diabetes Patients Treated With Insulin Pumps in the Outpatient Clinic
https://clinicaltrials.gov/ct2/show/NCT04612933

Jul 8th, 2021 - Telemedicine also has the potential to be a cost-effective solution due to reductions in travelling costs and saved working days, as well as increased patient satisfaction due to the reduction in transportation time. Several studies have evaluated...

see more →

News  195 results

Advances in Diabetes and Cardiovascular Care
https://www.mdedge.com/fedprac/article/251040/diabetes/advances-diabetes-and-cardiovascular-care

Jan 20th, 2022 - Real-World Experience With Automated Insulin Pumps Continuous Blood Glucose Monitoring for T2DM Statin-Induced Adverse Effects Long QT and Cardiac Arrest After Pulmonary Edema And more online • Clinical Impact of U-500 Insulin Initiation • Diabete.

Medicare Expands Coverage of Continuous Glucose Monitoring Devices for Diabetes
https://www.medscape.com/viewarticle/965693

Dec 28th, 2021 - The Centers for Medicare & Medicaid Services (CMS) has finalized a rule to expand Medicare coverage to include continuous glucose monitoring (CGM) devices that are not approved for making treatment decisions. Proposed in November 2020, the final C...

Antibody Tx Fail; Omicron Cases Rise in the U.S.; NFL Mandates Boosters for Coaches
https://www.medpagetoday.com/infectiousdisease/covid19/96208

Dec 15th, 2021 - Adagio raised more than $750 million to develop a neutralizing antibody that would treat various forms of COVID, but its latest effort appears to be a bust against Omicron. (Endpoints News) The highly infectious variant now accounts for about 3% o...

Wide Racial Gap for Diabetes Tech Use Among Medicare Patients
https://www.medpagetoday.com/endocrinology/type1diabetes/96206

Dec 15th, 2021 - The use of insulin pumps and continuous glucose monitors (CGMs) increased in recent years among Medicare beneficiaries with type 1 diabetes, but so did disparities in usage between Black and white patients, researchers reported. From 2017 to 2019,...

Contact Allergens in Medical Devices: A Cause for Concern?
https://www.medscape.com/viewarticle/962558

Nov 9th, 2021 - Despite the clinical value of medical devices, there is a potential for these products to cause adverse skin reactions in some patients. Findings from a European retrospective study, published in the European Journal of Allergy and Clinical Immuno...

see more →